| Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy C Tovar, J Rosinski, Z Filipovic, B Higgins, K Kolinsky, H Hilton, X Zhao, ... Proceedings of the National Academy of Sciences 103 (6), 1888-1893, 2006 | 809 | 2006 |
| Integrated genomics and proteomics define huntingtin CAG length–dependent networks in mice P Langfelder, JP Cantle, D Chatzopoulou, N Wang, F Gao, I Al-Ramahi, ... Nature neuroscience 19 (4), 623-633, 2016 | 363 | 2016 |
| Molecular evolution of the Myb family of transcription factors: evidence for polyphyletic origin JA Rosinski, WR Atchley Journal of Molecular Evolution 46, 74-83, 1998 | 359 | 1998 |
| Huntington's disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels S Horvath, P Langfelder, S Kwak, J Aaronson, J Rosinski, TF Vogt, ... Aging (Albany NY) 8 (7), 1485, 2016 | 219 | 2016 |
| Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington's disease SDJ Plotkin JL, Day M, Peterson JD, Xie Z, Kress GJ, Rafalovich I ... Neuron 83 (1), 178-88, 2014 | 218 | 2014 |
| Resistance to selective BRAF inhibition can be mediated by modest upstream pathway activation F Su, WD Bradley, Q Wang, H Yang, L Xu, B Higgins, K Kolinsky, ... Cancer research 72 (4), 969-978, 2012 | 212 | 2012 |
| Microarray-based identification of differentially expressed growth-and metastasis-associated genes in pancreatic cancer H Friess, J Ding, J Kleeff, L Fenkell, JA Rosinski, A Guweidhi, ... Cellular and Molecular Life Sciences CMLS 60, 1180-1199, 2003 | 174 | 2003 |
| Cascades of transcriptional induction during dendritic cell maturation revealed by genome‐wide expression analysis Ö Türeci, H Bian, FO Nestle, L Raddrizzani, JA Rosinski, A Tassis, ... The FASEB journal 17 (8), 836-847, 2003 | 107 | 2003 |
| Phosphodiesterase 10A inhibition improves cortico-basal ganglia function in Huntington’s disease models V Beaumont, S Zhong, H Lin, WJ Xu, A Bradaia, E Steidl, M Gleyzes, ... Neuron 92 (6), 1220-1237, 2016 | 102 | 2016 |
| Dysfunction of the CNS-Heart Axis in Mouse Models of Huntington's Disease BGP Mielcarek M, Inuabasi L, Bondulich MK, Muller T, Osborne GF, Franklin SA ... PLoS Genetics 10 (8), 2014 | 91 | 2014 |
| The effect of insulin on expression of genes and biochemical pathways in human skeletal muscle X Wu, J Wang, X Cui, L Maianu, B Rhees, J Rosinski, WV So, SM Willi, ... Endocrine 31, 5-17, 2007 | 88 | 2007 |
| Molecular evolution of helix–turn–helix proteins JA Rosinski, WR Atchley Journal of molecular evolution 49, 301-309, 1999 | 72 | 1999 |
| Transcriptional regulatory networks underlying gene expression changes in Huntington's disease SA Ament, JR Pearl, JP Cantle, RM Bragg, PJ Skene, SR Coffey, ... Molecular systems biology 14 (3), e7435, 2018 | 67 | 2018 |
| Large-scale phenome analysis defines a behavioral signature for Huntington's disease genotype in mice V Alexandrov, D Brunner, LB Menalled, A Kudwa, J Watson-Johnson, ... Nature biotechnology 34 (8), 838-844, 2016 | 57 | 2016 |
| DNA methylation study of Huntington’s disease and motor progression in patients and in animal models AT Lu, P Narayan, MJ Grant, P Langfelder, N Wang, S Kwak, H Wilkinson, ... Nature communications 11 (1), 4529, 2020 | 54 | 2020 |
| MicroRNA signatures of endogenous Huntingtin CAG repeat expansion in mice P Langfelder, F Gao, N Wang, D Howland, S Kwak, TF Vogt, JS Aaronson, ... PloS one 13 (1), e0190550, 2018 | 49 | 2018 |
| RG7212 anti-TWEAK mAb inhibits tumor growth through inhibition of tumor cell proliferation and survival signaling and by enhancing the host antitumor immune response X Yin, L Luistro, H Zhong, M Smith, T Nevins, K Schostack, H Hilton, ... Clinical Cancer Research 19 (20), 5686-5698, 2013 | 39 | 2013 |
| Single Nucelotide Polymorphism (SNP) M Faham, S Germer, HB Jones, D Lagarde, ML Martin, ME Moorhead, ... US Patent App. 11/792,772, 2009 | 33 | 2009 |
| Myostatin inhibition prevents skeletal muscle pathophysiology in Huntington’s disease mice MK Bondulich, N Jolinon, GF Osborne, EJ Smith, I Rattray, A Neueder, ... Scientific reports 7 (1), 14275, 2017 | 32 | 2017 |
| Preclinical biomarkers for a cyclin-dependent kinase inhibitor translate to candidate pharmacodynamic biomarkers in phase I patients W Berkofsky-Fessler, TQ Nguyen, P Delmar, J Molnos, C Kanwal, ... Molecular cancer therapeutics 8 (9), 2517-2525, 2009 | 25 | 2009 |
